
    
      Primary objective:

      I To determine if dietary alternations designed to downregulate the dominate molecular
      drivers of an individuals' breast cancer will enhance the effect of neoadjuvant chemotherapy
      and allow for an increase in the pathologic complete response rate.

      Secondary objectives

      I) Investigator measurable changes to molecular and patient characteristics from precision
      nutrition to determine a metric for evaluation this treatment in future studies.
    
  